Summary
A novel peptide, islet amyloid polypeptide (IAPP), with structural resemblance to calcitonin gene-related peptide has recently been purified from amyloid deposits in an insulinoma and from islets of Langerhans. By immunohistochemical methods, using antisera to a synthetic undecapeptide of IAPP and to insulin, we show that freshly fixed islet B cells in man, guinea pig, rat, mouse and hamster exhibit strong IAPP-immunoreactivity while A cells are unreactive. In human autopsy material, all of 11 non-diabetic individuals had IAPP immunoreactivity of the islets. In comparison 8 of the 13 patients with Type 2 (non-insulin-dependent) diabetes had no IAPP immunoreactive cells. The proportion of islet cells having IAPP immunoreactivity exceeded 10% in only 1 of the 5 remaining diabetic patients while in all 13 patients substantially more than 10% of the islet cells contained immunoreactive insulin. IAPP-positive amyloid deposits were found in 20–99% of the islets in 12 of the Type 2 diabetic patients while 6 of 11 non-diabetic subjects had amyloid in 3–11% of their islets. In islets with IAPP-immunoreactive amyloid, very few IAPP-cells were seen despite a strong reaction of the B cells with antiserum to insulin. This study shows that IAPP is a normal islet B cell component and that IAPP immunoreactivity in B cells is diminished in Type 2 diabetes while IAPP is deposited as amyloid fibrils in the islets of Langerhans. Although the function of IAPP is unknown, its occurrence in the islet B cells and its structural relation to calcitonin gene-related peptide makes a hormonal nature probable. The present study indicates an altered expression or metabolic fate of IAPP in Type 2 diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Efendic S, Cerasi E, Elander I, Thornqvist C, Fick G, Berglund B, Luft R (1979) Studies on low insulin responders. Acta Endocrinol 90 [Suppl]: 224
O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC (1986) Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet II: 360–364
Maclean N, Ogilvie RF (1959) Observations on the pancreatic islet tissue of young diabetic subjects. Diabetes 8: 83–91
Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Maclean N, Ogilvie RF (1955) Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4: 367–376
Warren S, LeCompte PM, Legg MA (1966) The pathology of diabetes mellitus, 4 edn. Lea & Febiger, Philadelphia
Westermark P, Grimelius L (1973) The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Immunol Scand [A] 81: 291–300
Westermark P, Wilander E (1978) The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15: 417–421
Opie EL (1900) On relation of chronic interstitial pancreatitis to the islets of Langerhans and to diabetes mellitus. J Exp Med 5: 397–428
Ehrlich JC, Ratner IM (1961) Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Pathol 38: 49–59
Bell ET (1959) Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol 35: 801–805
Melato M, Antonutto G, Ferronato E (1977) Amyloidosis of the islets of Langerhans in relation to diabetes mellitus and aging. Beitr Pathol 160: 73–81
Westermark P (1973) Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch [A] 359: 1–18
Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827–831
Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a novel neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84: 3881–3885
Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987) Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 127: 414–417
Sternberger LA (1979) Immunocytochemistry, 2nd edn. John Wiley & Sons, New York
Lundqvist M, Wilander E (1983) A simple procedure for immunocytochemical- and silver-staining of endocrine cells in the same section. Acta Pathol Microbiol Immunol Scand [A] 91: 493–494
Westermark P, Cornwell GG III (1986) Varied composition and nature of senile localised amyloid: implications for varied mechanisms of pathogenesis. In: Glenner GG, Osserman EG, Benditt EP, Calkins E, Cohen AS, Zucker-Franklin D (eds) Amyloidosis. Plenum, New York, pp 659–668
Sletten K, Westermark P, Natvig JB (1976) Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143: 993–998
Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD (1974) β-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22: 1141–1158
Westermark P (1974) On the nature of the amyloid in human islets of Langerhans. Histochemistry 38: 27–33
Westermark P, Wilander E (1983) Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia 24: 342–346
Clark A, Cooper GJS, Lewis CE, Morris JF, Willis AC, Reid KBM, Turner RC (1987) Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet II: 231–234
Pettersson M, Ahren B, Böttcher G, Sundler F (1986) Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology 119: 865–869
Johnson KH, Hayden DW, O'Brien TD, Westermark P (1986) Spontaneous diabetes mellitus-islet amyloid compex in adult cats. Am J Pathol 125: 416–419
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Westermark, P., Wilander, E., Westermark, G.T. et al. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30, 887–892 (1987). https://doi.org/10.1007/BF00274799
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274799